No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection-Reference-Cited by-同舟云学术

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection

Published:2020-06 Issue:4 Volume:50 Page:384
ISSN:0399-077X
Container-title:Médecine et Maladies Infectieuses
language:en
Short-container-title:Médecine et Maladies Infectieuses

Author:

Molina J.M.,Delaugerre C.,Le Goff J.,Mela-Lima B.,Ponscarme D.,Goldwirt L.,de Castro N.

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference8 articles.

1. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;Wang;Cell Res,2020

2. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases;Al-Bari;Pharmacol Res Perspect,2017

3. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomised clinical trial;Gautret;Int J Antimicrob Agents,2020

4. A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 COVID-19);Chen;J Zhejiang Univ Sci,2020

5. Paradoxical effect of chloroquine treatment in enhancing Chikungunya virus infection;Roques;Viruses,2018

Cited by 612 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydroxychloroquine in SARS-CoV-2 infection: Understanding the misadventure;Journal of Acute Disease;2024-04

2. Efficacy and limitations of repurposed drugs and vaccines for COVID-19;Journal of Medicine, Surgery, and Public Health;2024-04

3. Evidence-based pharmacotherapy in cardiology. National guideline;Rational Pharmacotherapy in Cardiology;2024-03-29

4. Heart-on-a-chip systems: disease modeling and drug screening applications;Lab on a Chip;2024

5. Clinical management in the COVID-19 pandemic: Rheumatic disease;Management, Body Systems, and Case Studies in COVID-19;2024